MYGN Myriad Genetics, Inc.
$3.42▲ +1.79%
Healthcare
Other
After hours
$3.43▲ +0.29%
Sep 11, 7:50 PM ET
Volume 2.55M
Avg Volume (10D) 1.65M
Key Metrics & Fundamentals
Market Cap
$327.12M
P/E Ratio
–
Div Yield
–%
52W Range
2.74 - 8.59
% vs 50 MA
-19.04%
% vs 200 MA
-31.49%
RSI-14
48.7
MACD Histogram
+0.1000
Beta (1Y vs SPY)
1.08
Free Cash Flow
-$11.50M
Gross Rev
$190.70M
Gross Profit
$127.00M
EBITDA
-$26.00M
COGS
$63.70M
Operating Exp
$165.90M
Operating Income
-$38.90M
EBIT
-$38.90M
Pretax Income
-$42.60M
Net Income
-$43.20M
EPS (Diluted)
-0.46
Price & Volume History
Loading chart…
Recent News
UBS Adjusts Price Target on Myriad Genetics to $3.60 From $6, Keeps Neutral Rating
MT Newswires · Sep 9, 2026 1:29 PM
Therapeutics Stocks Q2 Recap: Benchmarking Myriad Genetics (NASDAQ:MYGN)
StockStory · Sep 8, 2026 4:55 PM
Adma Biologics (ADMA) Down 4.8% Since Last Earnings Report: Can It Rebound?
Zacks · Sep 4, 2026 3:30 PM
Piper Sandler (PIPR) Stock May Be Fully Valued After A Fresh Downgrade Call
Simply Wall St. · Sep 3, 2026 6:15 PM
Why Is Harmony Biosciences (HRMY) Up 12.1% Since Last Earnings Report?
Zacks · Sep 3, 2026 3:30 PM
Stocks making big moves yesterday: Myriad Genetics, Greenbrier, Tidewater, Strategy, and Charter
StockStory · Sep 2, 2026 5:08 PM
Why Myriad Genetics (MYGN) Stock Is Down Today
StockStory · Sep 1, 2026 8:10 PM
Myriad Genetics Shares Fall After Piper Sandler Downgrade
MT Newswires · Sep 1, 2026 6:14 PM
This Biotech Stock Got a Rare Double-Downgrade. Its Profitability Problem Just Got Worse.
Barrons.com · Sep 1, 2026 4:37 PM
Robinhood upgraded, Uber initiated: Wall Street's top analyst calls
The Fly · Sep 1, 2026 1:36 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See MYGN's money flow as a full page
Social Sentiment
No Reddit posts found for MYGN.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.